Is p-ANCA in ulcerative colitis directed against β-glucuronidase?

The Lancet

Volumn 341, Issue 8840, 1993, Pages 320-

  Kaneko, Kazunari ^a   Suzuki, Yoshiharu ^a   Yamashiro, Yuichiro ^a   Yabuta, Keijiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA GLUCURONIDASE; CATHEPSIN G;

ADULT; ANTIBODY DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; HUMAN; LETTER; POLYARTERITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCURONIDASE; HUMAN; PEROXIDASE;

EID: 0027531479     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)92686-N     Document Type: Letter

References (6)

1. The current status of neutrophil cytoplasmic antibodies
2. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease
3. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis
4. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis
5. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role
6. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis Crohn's disease and primary sclerosing cholangitis